Olmesartan medoxomil, a newly developed angiotensin ii type 1 receptor antagonist, protects against renal damage in advanced glycation end product (age)-injected rats

Sho Ichi Yamagishi, M. Takeuchi, H. Inoue

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Fingerprint Dive into the research topics of 'Olmesartan medoxomil, a newly developed angiotensin ii type 1 receptor antagonist, protects against renal damage in advanced glycation end product (age)-injected rats'. Together they form a unique fingerprint.

Medicine & Life Sciences